drugset / Trial / NCT00828919
Continuing Access to Axitinib (A406- AG- 013736 ) For Patients Previously Receiving AG 013736 In Clinical Trials
NaOpen-labelTreatment
Summary
To allow continuation of axitinib (AG 013736) treatment to patients experiencing clinical benefit in a closing axitinib trial
Timeline
- Start
- 2003-03-07
- Primary completion
- 2023-08-14
- Completion
- 2023-08-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Axitinib | Small molecule | — | Oral |
| Background | Crizotinib | Small molecule | — | Oral |